About the job
Innovators Wanted
Have you ever accomplished something that seemed impossible? If this prospect excites you, continue reading...
In 2015, we introduced a groundbreaking approach referred to as 'moneyball for biotech', consolidating innovative projects and promising early-stage research from academia under a unified financial framework to mitigate risk and foster innovation. This strategy enables scientific exploration and empowers small, expert teams to lead advancements. We strive to make significant contributions to the field of rare diseases, developing transformative medicines for patients with urgent unmet needs as quickly as possible.
At BridgeBio, we encourage creativity and challenge conventional thinking, seeking individuals who are eager to redefine the future of biopharma. Here, curiosity and experimentation are paramount, including the ethical and considered application of AI to enhance clarity, efficiency, and quality of work.
About BridgeBio Pharma, Inc.
BridgeBio is a biopharmaceutical company committed to the discovery, development, and delivery of transformative therapies for patients impacted by genetic diseases and genetically defined cancers. Since our inception in 2015, we have cultivated a diverse portfolio of over 20 drug development programs, ranging from early discovery to late-stage clinical trials, across various therapeutic areas, including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have successfully obtained regulatory approval for three therapies and are dedicated to translating promising scientific discoveries from academia into tangible treatments for patients globally.
